USD 90.34
(-0.65%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 16.62 Million USD | 13.01% |
2022 | 14.71 Million USD | 4.57% |
2021 | 14.06 Million USD | -72.05% |
2020 | 50.32 Million USD | 260.61% |
2019 | 13.95 Million USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | -100.0% |
2009 | 188 Thousand USD | 141.03% |
2008 | 78 Thousand USD | 85.71% |
2007 | 42 Thousand USD | 0.0% |
2006 | - USD | -100.0% |
2005 | 677 Thousand USD | -40.61% |
2004 | 1.14 Million USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 16.35 Million USD | 0.0% |
2024 Q2 | 15.81 Million USD | -3.28% |
2024 Q3 | - USD | -100.0% |
2023 Q4 | 16.62 Million USD | 17.63% |
2023 FY | 16.62 Million USD | 13.01% |
2023 Q1 | 14.44 Million USD | -1.78% |
2023 Q2 | 14.44 Million USD | 0.01% |
2023 Q3 | 14.13 Million USD | -2.19% |
2022 Q2 | 15.42 Million USD | 12.51% |
2022 Q3 | 14.89 Million USD | -3.39% |
2022 Q4 | 14.71 Million USD | -1.26% |
2022 Q1 | 13.7 Million USD | -2.57% |
2022 FY | 14.71 Million USD | 4.57% |
2021 Q4 | 14.06 Million USD | -3.58% |
2021 FY | 14.06 Million USD | -72.05% |
2021 Q1 | 42.84 Million USD | -14.86% |
2021 Q2 | 34.51 Million USD | -19.44% |
2021 Q3 | 14.58 Million USD | -57.73% |
2020 Q3 | 51.42 Million USD | -2.12% |
2020 Q4 | 50.32 Million USD | -2.14% |
2020 Q2 | 52.53 Million USD | 283.06% |
2020 Q1 | 13.71 Million USD | -1.72% |
2020 FY | 50.32 Million USD | 260.61% |
2019 FY | 13.95 Million USD | 0.0% |
2019 Q3 | 4.75 Million USD | -7.71% |
2019 Q4 | 13.95 Million USD | 193.48% |
2019 Q1 | 5.26 Million USD | 0.0% |
2019 Q2 | 5.15 Million USD | -2.11% |
2018 Q1 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2010 FY | - USD | -100.0% |
2010 Q3 | 156 Thousand USD | 13.87% |
2010 Q2 | 137 Thousand USD | -8.05% |
2010 Q1 | 149 Thousand USD | -20.74% |
2010 Q4 | - USD | -100.0% |
2009 Q4 | 188 Thousand USD | 0.53% |
2009 FY | 188 Thousand USD | 141.03% |
2009 Q2 | 68 Thousand USD | -13.92% |
2009 Q1 | 79 Thousand USD | 1.28% |
2009 Q3 | 187 Thousand USD | 175.0% |
2008 Q1 | 45 Thousand USD | 7.14% |
2008 FY | 78 Thousand USD | 85.71% |
2008 Q4 | 78 Thousand USD | 95.0% |
2008 Q3 | 40 Thousand USD | -11.11% |
2008 Q2 | 45 Thousand USD | 0.0% |
2007 FY | 42 Thousand USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q4 | 42 Thousand USD | 0.0% |
2006 FY | - USD | -100.0% |
2006 Q4 | - USD | -100.0% |
2006 Q3 | 2.82 Million USD | 553.7% |
2006 Q1 | 546 Thousand USD | -19.35% |
2006 Q2 | 432 Thousand USD | -20.88% |
2005 FY | 677 Thousand USD | -40.61% |
2005 Q4 | 677 Thousand USD | 0.0% |
2004 Q4 | 1.14 Million USD | 0.0% |
2004 FY | 1.14 Million USD | 0.0% |
2002 FY | - USD | 0.0% |
2001 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 75.25 Million USD | 77.909% |
AngioDynamics, Inc. | 3.93 Million USD | -322.036% |
AtriCure, Inc. | 60.59 Million USD | 72.564% |
Avinger, Inc. | - USD | -Infinity% |
Azenta, Inc. | 60.43 Million USD | 72.493% |
BioLife Solutions, Inc. | 18.31 Million USD | 9.213% |
The Cooper Companies, Inc. | 2.52 Billion USD | 99.341% |
Daxor Corporation | 755.65 Thousand USD | -2099.934% |
Ekso Bionics Holdings, Inc. | 4.83 Million USD | -244.04% |
Femasys Inc. | 4.25 Million USD | -290.402% |
GlucoTrack, Inc. | 196 Thousand USD | -8381.633% |
Harvard Bioscience, Inc. | 30.7 Million USD | 45.857% |
Hologic, Inc. | 2.49 Billion USD | 99.334% |
ICU Medical, Inc. | 1.57 Billion USD | 98.946% |
Intuitive Surgical, Inc. | -82.1 Million USD | 120.248% |
KORU Medical Systems, Inc. | 3.65 Million USD | -355.088% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Masimo Corporation | 871.7 Million USD | 98.093% |
Microbot Medical Inc. | 40 Thousand USD | -41460.0% |
Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -361920.906% |
Merit Medical Systems, Inc. | 823.01 Million USD | 97.98% |
Nephros, Inc. | 1.39 Million USD | -1095.971% |
NovoCure Limited | 596.24 Million USD | 97.212% |
NEXGEL, Inc. | 513 Thousand USD | -3140.546% |
NEXGEL, Inc. | 513 Thousand USD | -3140.546% |
Singular Genomics Systems, Inc. | 67.52 Million USD | 75.381% |
OraSure Technologies, Inc. | 11.38 Million USD | -45.978% |
Pro-Dex, Inc. | 7.53 Million USD | -120.594% |
Pulse Biosciences, Inc. | 8.08 Million USD | -105.59% |
Predictive Oncology Inc. | 2.18 Million USD | -659.441% |
Precision Optics Corporation, Inc. | 1.93 Million USD | -757.805% |
QuidelOrtho Corporation | 2.27 Billion USD | 99.269% |
Repligen Corporation | 510.14 Million USD | 96.741% |
Sanara MedTech Inc. | 9.11 Million USD | -82.418% |
STAAR Surgical Company | 31.46 Million USD | 47.17% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 295 Thousand USD | -5535.254% |
DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.074% |
Jin Medical International Ltd. | - USD | -Infinity% |